Refine by
Industries served
- Medical / Health Care
- Agriculture
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Environmental
- Energy
- Mining
- Automobile & Ground Transport
- Defense
- Domestic
- Aerospace & Air Transport
- Forestry & Wood
- Pulp & Paper
- Real Estate
- Waste and Recycling
- Oil, Gas & Refineries
- Water and Wastewater
- Health and Safety
- Manufacturing, Other
- Food and Beverage
- Construction & Construction Materials
Disease Severity Suppliers & Manufacturers
96 companies found
based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
based inBoston, MASSACHUSETTS (USA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...
based inWellesley Heights, MASSACHUSETTS (USA)
Novel point-of-care diagnostics for earlier disease detection. SANO Diagnostics is developing a range of disposable, cost-effective point-of-care diagnostics to detect the early onset of inflammation in several disease states. We are a development ...
based inOxford, UNITED KINGDOM
The Native Antigen Company has developed a proprietary HEK293 mammalian expression system (VirtuE) for expression of recombinant proteins. The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease ...
Recombinant Chikungunya Virus-Like Particles produced in mammalian HEK293 cells. Chikungunya structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. ...
based inWayne, PENNSYLVANIA (USA)
Vesper Medical is a privately held company shaping the future of treating deep venous disease through the creation of a next-generation, modular, and uniquely engineered venous stent portfolio that addresses the multiple anatomical challenges ...
The Vesper DUO Venous Stent System® is designed to be the next generation venous stent portfolio uniquely engineered to address the multiple anatomical challenges of the deep venous system, providing physicians with a modular portfolio to ...
based inAichi, JAPAN
Nidek offers a wide array of equipment designed for the diagnosis and treatment of retinal diseases, glaucoma, and other vision-impairing afflictions. Our aim is to avail the field with products of unmatched quality, service, and value. Since its ...
based in, NETHERLANDS
At veriNOS Pharmaceuticals, we focus on the clinical development of a drug that specifically inhibits a defined cascade that is relevant and common in different disease settings. The activation of iNOS with subsequent excessive production of cell ...
Ronopterin is an allosteric inhibitor of inducible NO synthase (iNOS) that rapidly decreases the excessive production of NO resulting from acute overactivation of this enzyme. Ronopterin has no significant effect on the physiological production of ...
based inMonmouth Junction, NEW JERSEY (USA)
DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...
microRNAs are a class of small non-coding regulatory RNA molecules, which modulate target gene expression and protein production, and whose levels often change in disease. Certain microRNAs are enriched, i.e. present at higher concentration, in ...
based inWaltham Abbey, UNITED KINGDOM
Founded in May 2020, KoKo extends the legacy of medical technology companies that have been advancing respiratory science dating back to the Iron Lung in the 1930’s. Decades of innovation led us to being a leading respiratory information systems ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inSunnyvale, CALIFORNIA (USA)
Our mission: To help deliver brighter patient outcomes. One procedure at a time. Each and every one of us at Silk Road Medical is inspired by the power of the human mind and have dedicated ourselves to protect it by developing advanced solutions ...
based inBrignais, FRANCE
ENDALIS has developed END BALL, a non-surgical, temporary intragastric balloon system for the treatment of obesity. The intragastric balloon acts through the filling of the stomach which causes a feeling of satiety and a reduction of food intake. ...
based inNess Ziona, ISRAEL
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic ...
BX003 is an orally administered phage cocktail targeting a bacterial target present in the gut of IBD and PSC patients and thought to be associated with the onset or exacerbation of these diseases. Although different organs are affected in IBD and ...
based inJeddah, SAUDI ARABIA
Gulf Medical Company was founded in 1983 as a medical supply company specialized in the sales and marketing of medical devices and equipment, with the sole proprietorship of the vision “To bring the most innovative state of the art medical ...
based inSan Marcos, CALIFORNIA (USA)
ACI Medical, LLC is a biomedical engineering firm engaged in the research, development, manufacture and sale of therapeutic products and technologies for individuals with varying degrees of limb- and life-threatening vascular conditions. With more ...
based inDanvers, MASSACHUSETTS (USA)
Abiomed is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily ...
The Impella CP with SmartAssist heart pump allows for sustained peak flows of up to 4.3 L/min (>85% of a normal cardiac cycle). It is designed to improve patient outcomes by using real-time intelligence to optimize positioning, ...
based inStockholm, SWEDEN
BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of disorders that affect the Central Nervous System. These types of treatments are commonly referred to as disease modifiers. They ...
BioArctic has developed a technology platform that has proven to be successful when the company’s first drug candidate was developed, the antibody BAN2401 for Alzheimer´s disease. Our mission is to improve quality of life for patients ...
based inNew Taipei City, TAIWAN
ACME Dynacardia is a partnership between ACME Portable and Dynacardia. With over 23 years of experience, ACME Portable specializes in manufacturing and building high-performance, unique computers that are customized specifically for special ...
ACME Non-invasive Ischemia Detector (ACME NID) is a reliable, non-invasive tool for ischemia detection algorithm. It is a patented algorithm that analyzes 10 second 12 lead ECG captured by either our own QED 2000 or a certified off-the-shelf ECG ...
based inRancho Dominguez, CALIFORNIA (USA)
DxTerity is a patient-centric genomics company passionate about putting patients with immune-mediated diseases at the center of everything that we do. We’re harnessing the power of real-world genomics with convenient from-home RNA monitoring to help ...
Autoimmune diseases need analysis tools that go beyond superficial symptoms to recognize the distinct immune system activity of each patient. Modular transcriptome repertoire analysis 1, also known as modular genomics, shows tremendous promise for ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Chitosan oligosaccharide (COS) is an oligomer of β-(1→4)-linked D-glucosamine. Chitosan oligosaccharide (COS) activates AMPK and inhibits inflammatory signaling pathways including NF-κB and MAPK ...